Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy

23 Jul 2025

Abstract excerpt

Diabetic cardiomyopathy (DCM) is a prominent contributor to morbidity and mortality in people with diabetes worldwide. In diabetic patients, it is a chronic condition that is characterized by ventricular hypertrophy (VH), diastolic dysfunction, alteration of systolic function, and reduced ejection fraction, ultimately leading to heart failure (HF). Despite being extensively understood, the underlying causes of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40771931
DOI: 10.3389/fphar.2025.1613844

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathyPMID 40771931Read ↗

Role of microRNAs in the pathogenesis of diabetic cardiomyopathySemantic proximity Read ↗

The role of microRNAs in the pathophysiology, diagnosis, and treatment of diabetic cardiomyopathySemantic proximity Read ↗

MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeuticsSemantic proximity Read ↗

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAsSemantic proximity Read ↗

Pathogenesis of Diabetic Cardiomyopathy and Role of miRNASemantic proximity Read ↗

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy.Semantic proximity Read ↗

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic CardiomyopathySemantic proximity Read ↗

The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old EntitySemantic proximity Read ↗

Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological StrategiesSemantic proximity Read ↗

The role of exosomes and exosomal microRNA in diabetic cardiomyopathySemantic proximity Read ↗

Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathySemantic proximity Read ↗

Established and Emerging Roles of Epigenetic Regulation in Diabetic CardiomyopathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.